THE RELEVANCE OF PNEUMOCOCCAL DISEASE
Streptococcus pneumoniae (the pneumococcus) causes infectious diseases such as pneumonia, septicaemia and meningitis and is one of the most common infectious agents of humans, leading to illness and death in millions of individuals every year. The pneumococcus causes more deaths from invasive infections than any other bacterium and is the fifth leading cause of death worldwide. 1 In developing countries in particular, pneumococcal infection places a heavy burden on health resources and on the socio-economic development of those societies. These facts mean that considerably more emphasis should be given to the mechanisms of pathogenesis of pneumococcal disease; in particular, the host-bacterial interactions and the host immune defence against pneumococcal invasion. Previous attempts to identify the gene(s) explaining differing susceptibility to pneumococcal disease in humans have been without significant success. For pneumococcal disease, segregation analysis and genome-wide analysis in humans is not possible because there are insufficient sibling cases or multi-case families. Moreover, the acute nature of pneumococcal disease makes this particularly problematic.
Determination of the gene(s) conferring susceptibility would be a noteworthy advance in the understanding of invasive pneumococcal disease. To overcome the problem of the lack of caseconfirmed pedigrees and sibling pairs for the study of human susceptibility to pneumococcal disease, and in order to identify new candidate genes and develop new hypotheses on mechanisms of innate resistance to pneumococcal disease, mouse models of infection and disease are highly desirable. As there is no possibility of following the course of pathogenesis in the human host, a significant proportion of the information that has been obtained on pneumococcal disease in vivo has come from mouse studies. Indeed, the mouse is by far the most commonly used animal for the study of pneumococcal disease. Mouse models are also extremely valuable tools for dissecting the key features of pneumococcal virulence and the host immune responses to infection. Not only are genes found by this approach likely to open up new hypotheses on pathogenesis and disease resistance, they are credible candidates for human association studies, even if the exact polymorphisms may differ in the two species. It has been known for some time, however, that experimental animals vary in susceptibility to pneumococcal disease. The genetic basis of susceptibility to the bacterium is unknown.
Human susceptibility to infectious disease is a complex trait with a strong genetic component. The evidence supporting these conclusions has been extensively discussed in several excellent reviews. [2] [3] [4] [5] This review will summarise the current knowledge on mouse susceptibility and resistance to pneumococcal infection. Components of host immune responses to pneumococcal infection and the role of pneumococcal virulence factors will not be addressed within the scope of this review, as several other detailed reviews already exist in that field.
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THE FIRST CLUES OF SUSCEPTIBILITY TO PNEUMOCOCCAL INFECTION
In 1909, Clarence Cook Little -a Harvard biologist -developed the first inbred mouse strain: the DBA (dilute brown non-agouti). Little was convinced that studying a genetically pure breed would help him to determine the genetic basis of human disease. Together with Ernest Tyzzer, in 1916, Little showed that tumours transplanted between mice of the same strain were not rejected, but that mice of different strains rejected their transplants. This clearly indicated that genetically different strains of mice responded differently to similar pathological stimuli. Indeed, for over 70 years, since Webster's first experiments, 12 it has been known that mice can be selectively bred for susceptibility or resistance to infection. Webster, using the pathogen Salmonella enteritidis, developed resistant and susceptible lines of mice by selective breeding. 13 To investigate whether susceptibility or resistance of these mice occurred with other pathogens, Webster included the pneumococcus, as well as other bacterial and viral pathogens, in her experiments. 13 Mice susceptible to S. enteritidis were also found to be susceptible to two type 3 pneumococcal isolates from cases of human pneumonia, another type 3 pneumococcal isolate from a healthy carrier and a type 8 isolate from yet another case of human pneumonia; however, this observation was only seen when mice were challenged by intranasal administration. After either intraperitoneal or intravenous infection, no differences between susceptible and resistant lines of mice were observed, even when the dose was modified. 13 Indeed, this route-dependent variance in virulence was also observed when a pneumococcal strain given intraperitoneally was virulent, yet when given intranasally became avirulent.
14 In fact, Webster and Clow 14 not only provided evidence that mice presented distinct individual responses to different routes of pneumococcal infection, but also that individual breeds of mice were either resistant or susceptible to intranasal infections.
Building upon these earlier observations, Geoffrey Rake 15 published his milestone paper describing different pathological outcomes in different strains of mice given the same pneumococcal serotype by the same infection route. In addition, he also demonstrated that infection with different pneumococcal serotypes induced different intensities of pathology in the lungs of the same breed of mice. Rake 15 found that lesions induced in the lungs during pneumococcal pneumonia varied with the mouse strain used and that these lesions also varied when different pneumococcal isolates were administered into the lungs of individual mouse strains. This was the first clear indication that mice could be classified into resistant or susceptible phenotypes based upon their Early indications of the genetic basis of disease response to infection by a single pneumococcal serotype and that different pneumococcal serotypes induced different phenotypes in a single inbred strain of mouse.
The concept that, in resistance or susceptibility to pneumococcal infection, the genetic background of the host is as important as the genetic make-up of the pathogen, was addressed further by Briles and colleagues in the early 1980s. 16 They demonstrated that when two different pneumococcal serotypes were infected intravenously into different inbred strains of mice, susceptibility to infection not only varied between the mouse strains but also according to the pneumococcal serotypes, 16 confirming the previous findings of Rake. Furthermore, Briles and colleagues attempted to associate the phenotypic outcomes of resistance and susceptibility to infection with individual genes. For this purpose, recombinant inbred mice, which had been previously obtained by crossing disease resistant C57BL/6J mice with disease susceptible C3H/HeJ mice (BXH strains) and resistant C57L/J mice with susceptible AKR/J mice (AKXL strains), were used. 17 These mice were then challenged with a type 1 or a type 3 pneumococcal strain. Following analysis of the phenotypic traits of these mice and the known distribution of parental alleles, resistance to S. pneumoniae was statistically linked to the Akp-1 locus in the recombinant inbred strains (abbreviated as AKXL) which had descended from the AKR/J and C57L/J strains infected with the type 3 strain WU2; 17 however, no further study has been performed to confirm this association. Akp-1 is found on murine chromosome 1 and is known to encode alkaline phosphatase-1. 18 Susceptibility to pneumococcal infection has also been linked to the xid locus in mice. The X-linked inheritance of the xid mutation in mice produces an inability to mount a humoral antibody response to a group of thymusindependent carbohydrate antigens. 1, 19, 20 The xid locus is found in the CBA/N mouse strain. Consequently these mice are incapable of producing antibodies against pneumococcal polysaccharide and phosphocholine and they are highly susceptible to pneumococcal disease. 21 Even though there is evidence that antiphosphocholine antibodies are an important part of the innate immune response to infection, [22] [23] [24] however, more recent work suggests that the CBA/N mouse is susceptible to pneumococcal infection not only because of the xid locus defect but also because of a combination of other, as yet undescribed, genes. 20, 25 Indeed, CBA/J mice which do not carry the xid mutation are equally as susceptible to pneumococcal infection as the xid genotype-carrying CBA/N strain. 17 In other studies by Benton and colleagues, the role of the pneumococcal toxin pneumolysin during intravenous infections was shown to be dependent on the genetic background of the mice used, irrespective of the xid locus. 26 Growth of pneumolysin-sufficient and -deficient pneumococci following intravenous infections was comparable in CBA/N and C3H/HeJ mice, yet was different in C57BL/6J and 129/SvJ mice; 26 however, further exploration of the genetic basis of these observations has not been reported.
WHERE DO WE STAND TODAY?
The question regarding the role of genetic background in susceptibility to pneumococcal disease was recently revisited in detail in two studies. Nine inbred strains of mice were intranasally infected in a model of pneumococcal bronchopneumonia and bacteraemia, with subsequent mapping of a major locus controlling survival and invasive bacteraemia. 27, 28 Following intranasal infections with a serotype 2 pneumococcus, mouse strains differed markedly in their susceptibility to disease, as quantified by survival time and numbers of pneumococci in the blood. This was clearly indicated by the observation of highly susceptible phenotypes (CBA/Ca and SJL) and a Attempts to associate phenotypic outcomes of susceptibility to individual genes highly resistant phenotype (BALB/c) with intermediate to resistant strains scattered in between (in sequential order, from susceptible to resistant: C3H/He, FVB/n, NIH, AKR, C57BL/6 and DBA/2; see Figure 1 ). The variation in the distribution of phenotypes suggested that resistance to pneumococcal infection was a complex trait, yet the authors did not rule out the possibility of a single gene effect generated from allelic variation in these inbred strains. 27 In further analysis of the most susceptible and resistant strains, susceptible CBA/Ca mice developed an early sepsis extending into an uncontrolled bacterial increase, while in resistant BALB/c mice, only a transient bacteraemia was observed. 27 The limiting factor in the development and progression of bacteraemia appeared to depend on the numbers of pulmonary bacteria; the BALB/c mice were able to maintain these at low levels, whereas CBA/Ca mice were unable to prevent rapid pneumococcal growth in their lungs. When the immune cellular response in the lungs of these two strains was analysed, it was apparent that a much more vigorous immune response was elicited in the resistant BALB/c strain than in the CBA/Ca strain, with neutrophils being the predominant leukocyte type. The rate of neutrophil influx was far greater in BALB/c mice, with consequent clearance of pneumococci in their lungs, than in CBA/Ca mice. 27 Further studies also showed significantly more mast cells in the lungs of resistant BALB/c mice; these were shown to release more tumour necrosis factor-alpha (TNF-AE) when stimulated with pneumococci. 29 The airways and lung tissue of infected BALB/c mice contained greater TNF-AE and interleukin (IL)-10 concentrations than in CBA/Ca mice, whereas IL-6 levels were higher in the lungs of CBA/ Ca mice following pneumococcal infection. 29 These observations have recently been supported in another study using a pneumococcal model leading to lobar pneumonia, rather than the bronchopneumonia model used above. In this study, BALB/c and C57BL/6 mice infected intratracheally with a serotype 3 pneumococcus, also exhibited a quantitative difference in their immune responses to infection. 30 Indeed, as in the study by Gingles et al., 27 Preston et al. found that BALB/c mice had a more intense and rapid neutrophil influx into the lungs following infection than did C57BL/6 mice. 30 The authors concluded that inflammatory differences between the two strains were mouse strain-dependent, rather than as a result of pneumococcal dose or toxicity. 30 Significantly, the authors also showed increased phagocytic activity and oxidative burst in bronchoalveolar macrophages and neutrophils from BALB/c compared with C57BL/6 mice following infection. The authors' conclusion that mice with a Th2 background (BALB/c) are less susceptible to pneumococcal infection than are mice with a Th1 background (C57BL/6), however, was based on infection studies conducted with Leishmania major and not with pneumococci. 31, 32 Hence, there is no direct evidence that these strains of mice would express similar T cell profiles during infection with pneumococci as during a protozoan infection. Clearly, however, the concept of T cell-mediated differences underlying genetic susceptibility to disease is an intriguing hypothesis that warrants further research. Evidence that differences in neutrophil recruitment during infection could be the basis of susceptibility also comes from other models of infection. For example, in an infection model of bronchial inflammation with Pseudomonas aeruginosa, resistant BALB/c mice showed greater recruitment of neutrophils into the bronchoalveolar spaces than did susceptible DBA/2 mice, which were unable to clear the infection. 33 Interestingly, DBA/2 mice were found to be deficient in complement protein C5. 33 In the studies by Gingles et al., DBA/2 mice were significantly more resistant to pneumococcal infection than were susceptible CBA/Ca mice, but the former were also more susceptible to disease than the resistant BALB/c mice; 27 hence, the connection with complement protein C5 requires further analysis.
MOUSE GENOMIC STUDIES
Recruitment of neutrophils during infection has been reported to be controlled by genes associated with the mouse H2 haplotype, as well as by genes outside the major histocompatibility complex. 34 In experiments carried out by Gingles and colleagues, 27 the CBA/Ca strain with an H2 k haplotype was significantly more susceptible to disease than the H2 k AKR strain. A recent study using linkage analysis of the F2 generation from a cross between resistant BALB/c and susceptible CBA/ Ca strains has detected a major quantitative trait locus conferring susceptibility to pneumococcal infection, as determined by the severity of invasive disease and by survival rates. 28 Based on genomic scans performed on 184 F2 mice with a set of polymorphic markers, a single major linkage with survival and bacteraemia on proximal chromosome 7 was revealed within a region of approximately 8 centimorgans (cM) close to the locus D7Mit77 (LOD ¼ 6.34; p , 0.001 for survival and LOD ¼ 4.62; p , 0.01 for bacteraemia). 28 This region shows complete conservation of synteny with human chromosome 19q13.1-q13.3. When the data were analysed for sexual predisposition, it was found that the evidence for linkage for each phenotype came largely from male mice. 28 The proportions of surviving mice by genotype at D7Mit77 did not show a significant sex difference (for each sex, nearly half of the BALB/c homozygotes survived, while very few of the CBA/Ca homozygotes did), however, suggesting that, regardless of sex, the BALB/c allele behaves as dominant, conferring infection resistance and survival while the CBA/Ca allele confers susceptibility. 28 The location of the survival trait locus on mouse chromosome 7 lies in the region between D7Mit341 and D7Mit247, which intriguingly also includes several genes encoding for molecules associated with inflammation and innate immunity, such as the tyrosine kinase-binding protein gene (Tyrobp), the platelet activating factor acetylhydrolase 1B gamma subunit gene (Pafah1b3), the haematopoietic cell signal transducer gene (Hcst) and the gene for nuclear factor-kB inhibition (IKB-b), among others. There are, however, no cytokine or chemokine genes in this region. Since this 8 cM (11 megabase) region contains at least 197
Detection of a major locus conferring susceptibility to pneumococcal infection genes (http://www.ensembl.org/ Mus_musculus/), the present authors plan to use high-resolution mapping of interval-specific congenic strains in order to eliminate several candidate genes, followed by microarray expression profiling to analyse the remaining genes. 28 It is clear, however, that the elucidation of the gene(s) involved is a highly interesting prospect.
CONCLUSIONS
Mouse models provide an important tool for dissecting genetic linkages to human disease and for studying the functions of these genetic elements in vivo. By comparative mapping, resistant loci identified in the mouse genome can be searched for in the human genome, and similarly identified human disease loci can be tested in appropriate in vivo mouse models of disease. Identified genes can be used in mutational analysis in the mouse further to elucidate their functionality. Mouse models of infection provide an important tool in examining both genetic inheritance and the dissection of the biology behind such genetic traits. Determination of the gene(s) conferring susceptibility to infection would be a noteworthy advance in the understanding of the pathogenesis of invasive pneumococcal disease. It is expected that a better understanding of these processes will identify new targets for therapy and vaccination.
